Results 121 to 130 of about 53,524 (287)
Neurofilament Light Chain and Mutant Huntingtin Across Huntington's Disease Integrated Staging System Stages in Huntington Disease: A Cross‐Sectional Multimodal Analysis
Movement Disorders, EarlyView.Abstract Background
The Huntington's Disease Integrated Staging System (HD‐ISS) provides a framework for staging HD but does not incorporate fluid biomarkers. Objective
The aim of this study was to examine neurofilament light chain (NfL) and mutant huntingtin (mHTT) and total tau across HD‐ISS stages and their associations with genetic burden ...Jesús Pérez‐Pérez, Gonzalo Olmedo‐Saura, Arnau Puig Davi, Rocío Pérez González, Jordi Pegueroles, Andrea Horta‐Barba, Anna Vázquez Oliver, Elisa Rivas Asensio, Daniel Alcolea, Juan Fortea, Marina Guasch‐Jiménez, Tomas Xuclà Ferrarons, Frederic Sampedro Santaló, Lidia Bojtos, Óscar López‐Lombardía, Ignacio Aracil‐Bolaños, Berta Pascual‐Sedano, Carla Franch Martí, Laura Pérez Carasol, Margarita Rubio Romera, Yi Ji, Alexandre Gironell, Antonia Campolongo, Raul Martínez‐Fernández, Alberto Lleó, Javier Pagonabarraga, Saul Martínez‐Horta, Jaime Kulisevsky, BCN‐HD Working Group;, HDClarity investigators, Jesús Pérez‐Pérez, Gonzalo Olmedo‐Saura, Saül Martínez‐Horta, Arnau Puig‐Davi, Carla Franch, Paula Arranz‐Horno, Oscar López‐Lombardía, Lidia Bojtos, Antonia Campolongo, Javier Pagonabarraga, Jaime Kulisevsky, Asunción Ávila, Nuria Caballol, Alejandro Peral, Jesús Ruíz‐Idiago, Misericordia Floriach, Matilde Calopa, Helena Bejr Kasem, Clara Marzal Espí, Esteban Muñoz, Celia Painous, Irene Navalpotro, Victor Puente, Victoria González, Pau Pastor, Dolores Vilas, Iñigo Ruiz Barrio, Lourdes Ispierto, Eliot Gómez‐López, Claustre Pons, Gracia Pons, Maria Teresa Buongiorno, Anna Mas, Maria Pilar Gil, Jordi Casanovas, Edward Wild, Tiago Mestre, Mark Guttman, Philippe Rizek, Blair Leavitt, Carsten Saft, Bjorn Falkenburger, Juergen Winkler, Ralf Reilmann, Jan Lewerenz, Alzbeta Mühlbäck, Jesús Pérez‐Pérez, Tamara Fernandez Valle, José Luis López‐Sendón Moreno, Christophe Verny, Cyril Goizet, Caterina Mariotti, Ferdinando Squitieri, Tim Anderson, Richard Roxburgh, Grzegorz Witkowski, Leonor Correia Guedes, Hugh Rickards, Elizabeth Coulthard, Roger Barker, Anne Rosser, Tim Harrower, Robert Thompson, James Herron, Jeremy Cosgrove, Rhys Davies, Nayana Lahiri, Richard Armstrong, Daniel Lashley, Jee Bang, Erin Furr‐Stimming, Jessica Tate, Meagen Salinas, Karen Anderson, Amy Brown +104 morewiley +1 more sourceMultimodal Magnetic Resonance Imaging and Machine Learning Uncovers Distinct Progression Patterns in Friedreich Ataxia
Movement Disorders, EarlyView.Abstract Background
Friedreich ataxia (FRDA) is a rare neurodegenerative disorder with heterogenous clinical progression, complicating prognosis and trial design. Neuroimaging offers objective biomarkers of disease progression, yet variability in progression patterns remains poorly understood.Susmita Saha, Nellie Georgiou‐Karistianis, Vivienne Teo, Louise A. Corben, David J. Szmulewicz, Lachlan T. Strike, Marcondes C. França Jr., Thiago J.R. Rezende, Ian H. Harding +8 morewiley +1 more source无源光网络光纤复用拉远的技术方案分析
Guangtongxin yanjiu, 2016 为解决PON(无源光网络)传输距离受限问题,首先介绍了一种PON光纤复用拉远的技术方案,然后分析了其关键技术:PON信号聚合和PON拉远,该技术方案能够实现PON传输距离和传输容量的增加;最后介绍了两种应用场景。龙函, 胡毅doaj Skin Seed Amplification Assay Differentiates Multiple System Atrophy from Parkinson's Disease
Movement Disorders, EarlyView.Abstract Background
Misdiagnoses of multiple system atrophy (MSA) and Parkinson's disease (PD) remain common. Objective
The objective of the study was to develop a skin α‐synuclein seed amplification assay (αSyn‐SAA) for detecting pathological α‐synuclein and distinguishing MSA from PD.Anastasia Kuzkina, Diego Rodriguez, Celine Panzer, Alain Ndayisaba, Antonia Kohl, Shreya Rai, Breelyn Gilbert, Bruno Hammerschlag, Karie Shen, Lisa Harder‐Rauschenberger, Olivia Laun, Julia Meehan, Sucika Perumalla, Elena Salabasidou, Kristie Jones, Dalina Ceku, Robert Blum, Susanne Knorr, Camelia M. Monoranu, Claudia Sommer, Jens Volkmann, Barbara K. Changizi, Kathrin Doppler, Vikram Khurana +23 morewiley +1 more sourceAutomated Magnetic Resonance Volumetry to Measure Multiple System Atrophy Disease Progression in Clinical Trials
Movement Disorders, EarlyView.Abstract Background
Recent studies have reported longitudinal brain atrophy in multiple system atrophy (MSA) in relatively small patient cohorts. Objective
To compare longitudinal regional brain volume and clinical changes as endpoint measures for MSA clinical trials.Andrea Quattrone, Ida Wilkens, Zeyu Zhu, Irfan A. Qureshi, Nicolai Franzmeier, Günter U. Höglinger, for the M‐STAR Study Group, Phillip Low, Wolfgang Singer, Stuart Isaacson, Susan Perlman, Tao Xie, Zbigniew Wszolek, Diana Kerwin, Diana Apateurova, Theresa Zesiewicz, Roy Freeman, Rajesh Pahwa, Nikolaus McFarland, Eric Molho, Michael Geschwind, Rajeev Kumar, Sana Aslam, Dignity Health, Jee Bang, Aaron Ellenbogen, Italo Biaggioni, Andres Deik, Patricio Millar Vernetti, Jose‐Alberto Palma‐Carazo, Horacio Kaufmann, Pravin Khemani, Jeremy Schmahmann, Xuemei Huang, Irene Litvan, Mitchell Miglis, Deborah Hall, Sheng‐Han Kuo, Stewart Factor, Steven Vernino, Werner Poewe, Caroline Thun‐Hohenstein, Sophie Drapier, Alexandre Eusebio, Wassilios Meissner, Anne Pavy Le Traon, Christine Tranchant, Daniela Berg, Jost‐Julian Rumpf, Karla Eggert, Alfons Schnitzler, Lars Tönges, Jens Ebentheuer, Claudia Trenkwalder, Inga Claus, Tobias Warnecke, Guenter Hoeglinger, Annika Spottke, Nicola Pavese, Alessio DiFonzo, Paolo Barone, Huw Morris, Klaus Seppi +62 morewiley +1 more sourceEarly and Extensive Degeneration of Sensory Neurons in Spinocerebellar Ataxia Type 3
Movement Disorders, EarlyView.Abstract Background
Postmortem studies have shown significant degeneration of the peripheral nervous system (PNS) in spinocerebellar ataxia type 3 (SCA3). Although PNS involvement accelerates overall ataxia progression, PNS biomarkers for therapeutic trials are lacking and our mechanistic understanding of related clinical manifestations remains ...Milou Baarsma, Bart P.C. van de Warrenburg, Nens van Alfen, Roderick P.P.W.M. Maas +3 morewiley +1 more source